Tag: Pharmaceuticals

New Analysis from Landmark CREDENCE Study Shows the Efficacy and Safety Profiles of INVOKANA® (canagliflozin) are Consistent Across Various Levels of Kidney Function

Originally Published by Johnson & Johnson Analysis shows consistent renal and cardiovascular benefit when treated with INVOKANA® even when patients had moderate to severe renal deficiency INVOKANA® is the only diabetes medicine indicated to slow the progression of diabetic nephropathy (also known as DKD) and reduce the risk of hospitalization for heart…

Johnson & Johnson Announces Submission of European Marketing Authorization Applications for Janssen’s Investigational Ebola Vaccine Regimen

Originally Published by Johnson & Johnson Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have submitted Marketing Authorization Applications (MAAs) to the European Medicines Agency (EMA) seeking licensure for an investigational Ebola vaccine regimen for the prevention of Ebola Virus Disease (EVD) caused by Zaire ebolavirus species. Two MAAs…